Researcher.Life Logo

International Clinical Psychopharmacology : Impact Factor & More

eISSN: 1473-5857pISSN: 0268-1315

Key Metrics

CiteScore
3.7
H-Index
95
Impact Factor
< 5
SJR
Q2Pharmacology (medical)
SNIP
0.73
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on International Clinical Psychopharmacology

International Clinical Psychopharmacology Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher LIPPINCOTT WILLIAMS & WILKINS
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year1986
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in International Clinical Psychopharmacology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in International Clinical Psychopharmacology

Long-acting injectable vs. oral antipsychotics during electroconvulsive therapy in psychosis: a retrospective comparative study.
  • 1 Jul 2026
  • International clinical psychopharmacology
Antipsychotic polypharmacy in Japanese outpatients with schizophrenia: prevalence and sex- and age-related patterns.
  • 1 Jul 2026
  • International clinical psychopharmacology
Expanding the horizon of brexpiprazole augmentation in treatment-resistant disorders: from obsessive-compulsive disorder to adolescent bipolar disorder.
  • 1 Jul 2026
  • International clinical psychopharmacology
Antipsychotics in clinical practice: agitation, polypharmacy, and treatment resistance.
  • 1 Jul 2026
  • International clinical psychopharmacology
Acceptability-adjusted speed in psychotic agitation: interpreting pro re nata antipsychotic data in real-world care (commentary on Hatta et al.).
  • 1 Jul 2026
  • International clinical psychopharmacology
Risperidone- and paliperidone-induced hyperprolactinemia in routine clinical practice: demographic and pharmacological determinants from the UAE.
  • 1 Jul 2026
  • International clinical psychopharmacology
Long-acting injectable vs. oral antipsychotics during electroconvulsive therapy in psychosis: a retrospective comparative study.
  • 1 Jul 2026
  • International clinical psychopharmacology
Antipsychotic polypharmacy in Japanese outpatients with schizophrenia: prevalence and sex- and age-related patterns.
  • 1 Jul 2026
  • International clinical psychopharmacology
Expanding the horizon of brexpiprazole augmentation in treatment-resistant disorders: from obsessive-compulsive disorder to adolescent bipolar disorder.
  • 1 Jul 2026
  • International clinical psychopharmacology
Antipsychotics in clinical practice: agitation, polypharmacy, and treatment resistance.
  • 1 Jul 2026
  • International clinical psychopharmacology
Acceptability-adjusted speed in psychotic agitation: interpreting pro re nata antipsychotic data in real-world care (commentary on Hatta et al.).
  • 1 Jul 2026
  • International clinical psychopharmacology
Risperidone- and paliperidone-induced hyperprolactinemia in routine clinical practice: demographic and pharmacological determinants from the UAE.
  • 1 Jul 2026
  • International clinical psychopharmacology

FAQs on International Clinical Psychopharmacology